Alopexx
Manufacturing · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
186 Alewife Brook Pkwy 1068, Cambridge, ...Phone Number
(617) 780-1598Website
www.alopexx.comRevenue
<$5 MillionIndustry
About Alopexx
Alopexx Org Chart
Is Alopexx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Alopexx
Check out if Alopexx is spiking on competitors!
Alopexx, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Alopexx had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Alopexx launches new products
Funding: Get notified immidiatlly once Alopexx has new funding data
Earning: See what the market has to say on Alopexx recently announced quarterly report
Check if Alopexx has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Alopexx as Masked Content
Find 2 more new buyers
Compare Similar Companies to Alopexx
Compare insights from companies similar to Alopexx, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Alopexx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Alopexx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Alopexx.
Alopexx Tech Stack
A closer look at the technologies used by Alopexx
Most Recent Scoops
Alopexx News & Media
Alopexx Announces Investment from Biotech Consortia, Inc.
Investment supports product development and commercialization of a potentially life-saving vaccine Investment supports product development and commercialization of a potentially life-saving vaccineAlopexx Announces Presentation at IDWeek 2023
Presentation to include pre-clinical data on the molecular mechanisms of microbiota-driven neuroinflammation and the therapeutic potential of targeting PNAG in the treatment and prevention of Alzheimer's Disease CAMBRIDGE, Mass., Oct. 11, 2023 /PRNewswire/ -- Alopexx, Inc., a clinical...Alopexx, Inc. (ALPX) Plans to Raise $15 Million in October 6th IPO - The AM Reporter
Alopexx, Inc. (ALPX) expects to raise $15 million in an IPO on Thursday, October 6th, IPO Scoop reports. The company will be issuing 3,000,000 shares at a price of $5.00 per share. The company has a market cap of $39.2 million. ThinkEquity served as the underwriter for the IPO. Alopexx, Inc. provided the following description […]Alopexx Expands Leadership Team with Appointment of Thomas T. Thomas as Chief Financial Officer
CAMBRIDGE, Mass., Oct. 20, 2021 /PRNewswire/ -- Alopexx, Inc. a clinical stage biotechnology company focused on developing novel, broad-spectrum immune-mediated therapeutics for the prevention and treatment of bacterial, fungal and parasitic infections, today announced that Thomas T....
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Alopexx
Alopexx is a clinical stage biotechnology company focusing on developing novel, broad-spectrum immune-mediated therapeutics for the prevention, treatment and mitigation of a wide range of bacterial, fungal and parasitic microbial infections. They are based in Cambridge, Massachusetts.... Read More
